Palliative interventions for controlling vaginal bleeding in advanced cervical cancer

Area of Science:

• Oncology
• Palliative Care
• Gynecologic Oncology

Background:

• Cervical cancer is a leading cause of death for women globally, particularly in regions with limited screening programs.
• Advanced cervical cancer frequently presents with severe vaginal bleeding, a distressing and potentially life-threatening symptom requiring palliative management.
• Current literature lacks systematic reviews on palliative interventions for vaginal bleeding in advanced cervical cancer.

Purpose of the Study:

• To evaluate the efficacy and safety of interventions like tranexamic acid, vaginal packing, and interventional radiology.
• To compare these interventions against radiotherapy for palliative treatment of vaginal bleeding in advanced cervical cancer.
• To identify evidence-based options for managing a common and challenging symptom.

Main Methods:

• A systematic search was conducted for randomized and non-randomized comparative studies up to March 2018.
• Studies evaluated tranexamic acid, vaginal packing (with or without formalin), interventional radiology, or other interventions versus radiotherapy.
• Inclusion criteria focused on palliative treatment of vaginal bleeding in advanced cervical cancer.

Main Results:

• Despite extensive searching, no studies met the inclusion criteria for this systematic review.
• No randomized controlled trials were identified comparing the efficacy and safety of proposed interventions against radiotherapy.
• Only observational data from single-arm studies were found for formalin-soaked packs, interventional radiology, or radiotherapy.

Conclusions:

• There is currently no evidence from controlled trials to support or refute the use of interventions compared to radiotherapy for vaginal bleeding in advanced cervical cancer.
• The choice of intervention is currently based on local resources, as radiotherapy is not always accessible in resource-poor settings.
• A randomized controlled trial is urgently needed to assess the benefits and risks of palliative treatments for vaginal bleeding in women with advanced cervical cancer.